Stockreport

Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update [Yahoo! Finance]

Allogene Therapeutics, Inc.  (ALLO) 
Last allogene therapeutics, inc. earnings: 2/27 04:30 am Check Earnings Report
PDF Cema-cel Phase 1 ALPHA2 Trial in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL): Enrolling Patients with Initial Data Projected YE 2024 ALLO-329 in Autoimmune [Read more]